Page last updated: 2024-08-23

piperacillin and Allergic Bronchopulmonary Mycosis

piperacillin has been researched along with Allergic Bronchopulmonary Mycosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avidor, I; Gefen, A; Hakim, F; Kassis, I; Shachor-Meyouhas, Y; Weyl Ben-Arush, M; Zaidman, I1
Atalay, MA; Demir, K; Demiraslan, H; Doganay, M; Eren, E; Kaynar, L; Koc, AN1

Trials

1 trial(s) available for piperacillin and Allergic Bronchopulmonary Mycosis

ArticleYear
Serum galactomannan screening for diagnosis of invasive pulmonary aspergillosis in children after stem cell transplantation or with high-risk leukemia.
    Pediatric hematology and oncology, 2015, Volume: 32, Issue:2

    Topics: Adolescent; Adult; Allografts; Autografts; Child; Child, Preschool; Female; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Invasive Pulmonary Aspergillosis; Leukemia; Male; Mannans; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam

2015

Other Studies

1 other study(ies) available for piperacillin and Allergic Bronchopulmonary Mycosis

ArticleYear
Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia.
    Medical mycology, 2017, Jul-01, Volume: 55, Issue:5

    Topics: Anti-Bacterial Agents; Antigens, Fungal; False Positive Reactions; Febrile Neutropenia; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Microbiological Techniques; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2017